SAN FRANCISCO--(BUSINESS WIRE)--In 2024, Unlearn ® achieved key milestones in advancing AI to eliminate trial and error in medicine. From securing $50M in Series C ...

The next time you sign up for a drug study, you might just gain a new twin. Unlearn.AI creates AI-powered digital twins of individual patients in order to predict how their health may change over time ...

Dr. Howard Schubiner’s work in "Unlearn Your Pain" explores how chronic pain could be reversible with the right treatment.

Patient-level digital twins expected to strengthen evidence generation in Phase1/2 clinical study evaluating VTx-002, a first-in-class vectorized antibody targeting TDP-43 pathology in patients with ...

Throughout the history of medicine, drug developers have tried to make clinical trials faster and more efficient. Artificial intelligence and machine-learning methods are some of the newer approaches ...

While it is true that experiences are an indispensable part of learning to start a venture, we must not forget that focusing an idea on innovation and not on established paradigms can be much more ...

One summer in college I canvassed for a local non-profit. We went door to door telling people about the organization and asking them to sign various petitions. I recited my spiel a hundred times. “Hi, ...

While a lot of learning happens at Calvin University in any given week, the week of October 30—November 6, 2023, takes a different twist. Jane Bruin, director of the center for intercultural student ...